Selective serotonin reuptake inhibitors and risk reduction for cardiovascular disease in patients with schizophrenia: A controversial but promising approach.

Bellon, Alfredo; Nguyen, Kieuhanh

Bellon, Alfredo; Nguyen, Kieuhanh.

Afiliação

Bellon A; Department of Psychiatry and Behavioral Health, Penn State Hershey Medical Center, Hershey, PA 17033, United States. alfredobellon@yahoo.com.
Nguyen K; Department of Penn State College of Medicine, Penn State Hershey Medical Center, Hershey, PA 17033, United States.

World J Psychiatry ; 11(7): 316-324, 2021 Jul 19.

Article em En | MEDLINE | ID: mdl-34327124

Palavras-chave

Antidepressants; Antipsychotics; Body weight; Cholesterol; Metabolic syndrome; Psychotic disorders

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: World J Psychiatry Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google